Document Detail


Octreotide enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro.
MedLine Citation:
PMID:  22977639     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The present study aimed to investigate the effects of octreotide (OCT) on the reversal of resistance of cisplatin-resistant cancer cells and on enhancement of the cisplatin sensitivity of cancer cells. The 3-(4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide method and flow cytometry were used to investigate the effect of cisplatin, OCT or the combination of these two compounds on the proliferation and apoptosis of SKOV3/DDP cells. Real-time, quantitative RT-PCR was used to detect the mRNA expression of SSTR2, MDR1, MRP2, GST-π and EGFR in SKOV3/DDP cells following OCT treatment. At the concentration of 2.5-20 μg/ml, OCT significantly reduced the IC(50) value (P<0.05) and promoted apoptosis (P<0.05) in the SKOV3/DDP cells in response to cisplatin. The synergistic effect of OCT and cisplatin on SKOV3/DDP cell proliferation was observed. SSTR2 was expressed on the SKOV3/DDP cell surface. OCT increased GST-π expression (P<0.05) and reduced MRP2 and EGFR expression (P<0.05) in a dose-dependent manner. However, it had no effect on the expression of MDR1 (P>0.05). It is suggested that OCT inhibits ovarian cancer proliferation and promotes apoptosis, via the cell surface expression of SSRT2, and reverses cisplatin resistance through the inhibition of MRP2 and EGFR expression.
Authors:
Yang Shen; Mulan Ren; Yuehua Shi; Yunxia Zhang; Yunlang Cai
Related Documents :
23410519 - A common microrna signature consisting of mir-133a, mir-139-3p, and mir-142-3p clusters...
25109899 - Kpna2 is a promising biomarker candidate for esophageal squamous cell carcinoma and cor...
23563499 - Fabrication of a multi-layer three-dimensional scaffold with controlled porous micro-ar...
25044209 - Turmeric toxicity in a431 epidermoid cancer cells associates with autophagy degradation...
23331159 - Label free impedance detection of cancer cells.
23519249 - Microrna mir-491-5p targeting both tp53 and bcl-xl induces cell apoptosis in sw1990 pan...
1149039 - The pancreatic epithelial cell in vitro: a possible model system for studies in carcino...
25098609 - Gbp1 is one of the key molecules contributing to cancer cell radioresistance.
9242269 - Anticipatory time intervals of head-direction cells in the anterior thalamus of the rat...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-11
Journal Detail:
Title:  Experimental and therapeutic medicine     Volume:  2     ISSN:  1792-1015     ISO Abbreviation:  Exp Ther Med     Publication Date:  2011 11 
Date Detail:
Created Date:  2012-9-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101531947     Medline TA:  Exp Ther Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1171-1176     Citation Subset:  -    
Affiliation:
Department of Obstetrics and Gynecology, Zhongda Hospital, Southeast University, Nanjing 210009, P.R. China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Novel sequence variants and common recurrent polymorphisms of BRCA2 in Sri Lankan breast cancer pati...
Next Document:  Changes in serum thymidine kinase 1 levels during chemotherapy correlate with objective response in ...